Facebook
Twitter
LinkedIn
ForwardMiami Cardiac and Vascular Institute Grand Rounds: Expanding Destination Therapy: What Can We Expect in the Future?
Despite many medical advances and overall improving outcomes, end-stage heart failure (HF) is inevitable for some patients. While experimentation continues towards medical and biologic interventions aimed at end-stage HF, by far the greatest progress has been made in mechanical circulatory support, which is now a potential option to a wide range of patients. This success has been a long time in coming, but it has now reached a critical stage where therapeutic success of Left Ventricular Assist Devices (LVADs) make them an increasingly viable option in the non-transplant candidate. Dr. Robert L. Kormos will discuss requirements and regulations to support management of end-stage heart failure (HF) for the non-transplant candidate to improve patient outcomes.
| Live Event - Baptist Hospital - Auditorium |
| Webcast - To access the Webcast once it has started please CLICK HERE |
Target Audience
Cardiologists, cardiovascular surgeons, interventional cardiologists, interventional radiologists, general internists, intensivists, critical care physicians, emergency medicine physicians, hospitalists, nurses, nurse practitioners, physician assistants, occupational therapists, pharmacists, respiratory therapists and other interested healthcare providers.
Learning Objectives
- Discuss the key indications, risk factors for survival and adverse events for destination therapy for the management of end-stage heart failure (HF).
- List key elements of institutional infrastructure to support HF destination therapy and regulatory requirements to perform HF destination therapy.
- Implement strategies to support management of end-stage heart failure (HF) for the non-transplant candidate, and improve patient outcomes.
Robert L. Kormos, M.D., FRCS(C), FACS, FAHA
Brack G. Hattler Professor of Cardiothoracic Transplantation
Professor of Cardiothoracic Surgery and Bioengineering
Department of Cardiothoracic Surgery
Heart and Vascular Institute
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania
Robert L. Kormos, M.D., indicated that neither he nor his spouse/partner has relevant financial relationships with commercial interest companies, and he will not include off-label or unapproved product usage in his presentation or discussion.
Planning Committee:
James Benenati, M.D., indicated that he is a consultant for Penumbra, Gore, Cook, Bard Medical and Merit Medical.
Theodore Feldman, M.D., indicated that he is on the speakers’ bureau for Regeneron, Sanofi, Novartis and Boeringer Ingelheim.
Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose.
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been approved for 1.5 credit hours, CE Broker Course # 20-575265, by the Florida Boards of Medicine Osteopathic Medicine and by the Florida Council of Physician Assistants.
This activity has also been approved for 1.5 credit hours for Nursing, Nurse Practitioners, Occupational Therapists, Pharmacists and Respiratory Care (direct delivery). Baptist Health South Florida CE Broker Provider #50-182.
Available Credit
- 1.50 AMA PRA Category 1 Credit™
- 1.50 General certificate of attendance
- 1.50 Nurse Practitioners
- 1.50 Florida Board of Nursing
- 1.50 Florida Board of Occupational Therapy
- 1.50 Florida Board of Pharmacy
- 1.50 Florida Board of Respiratory Therapy
Pre-registration is required. Please log in to register.
To access the Webcast once it has started please CLICK HERE
Required Hardware/Software
Technical Support: If you are experiencing technical difficulties or have received an error message, please send an email to [email protected] and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.